Stephen Andrew Snyder, Chief Executive Officer at MEDICAL TRANSCRIPTION BILLING, CORP (MTBC), sold 53,729 shares at $5.04 ($271K) on 2018-11-27, disclosed to the SEC on 2018-11-28.
Open-market sale of $271k MTBC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.04 | 26,724 | $135K | 49.7% |
| 2 | $5.04 | 26,724 | $135K | 49.7% |
| 3 | $5.01 | 281 | $1K | 0.5% |
| Total | $5.04 avg | 53,729 | $271K | 100% |
| Filing → |
| MTBC | SELL | 2022-10-20 | $214K | — | Filing → |
| MTBC | SELL | 2022-10-07 | $40K | — | Filing → |
| MTBC | SELL | 2022-10-05 | $37K | — | Filing → |